As the FDA enforces the requirement for electronic data submission using SEND, pharmaceutical and biotech companies must adapt to this data-driven paradigm. PointCross Life Sciences emerges as a trusted partner, offering cloud-hosted or on-premises non-clinical solutions that streamline the process of becoming SEND ready. Embracing PointCross solutions empowers organizations to comply with regulatory mandates efficiently, optimize data management, and stay ahead of the curve in an increasingly data-centric industry. Contact PointCross today and embark on a seamless journey towards compliance with the FDA’s SEND mandate.
Related Posts
Xbiom: Biomarker Workbench for BioTech & Pharma
This draft white paper from PointCross Life Sciences Inc. (Foster City, CA) presents the opportunities for biomarker and biologics... read more
Sponsor conducting Xenograft studies on a tumor growth
Challenge: The study design is an involved lattice with multiple trial arms and with multiple CROs involved. Standard trial... read more
Workshop: A Workbench for Biomarker and Translational Research
April 17, 2019 | 8:00 am – 9:30am ET | Boston, MA 02210 read more
Incorporating Histopathology data of organs and tissues for terminal subjects from a draft PDF report
Challenge: Necropsy data and histopathology results were available only as a PDF report after the study’s conclusion. The CRO-provided... read more
